Finance Watch: As IPO Market Quiets Again, Xenon, Dianthus Price Big Follow-Ons

CRISPR, Indivior Sell $550m, $450m In Notes

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.